|
Parameters
|
SR (n = 9)
|
AF (n = 9)
|
Patients (n = 18)
|
P-value
|
|---|
|
Age
|
62 ± 3.3
|
67 ± 3.0
|
64.1 (44–84)
|
0.229
|
|
Female gender
|
22
|
22
|
22%
|
1.000
|
|
Diabetes
|
11
|
11
|
11%
|
1.000
|
|
EF
|
59 ± 4.9
|
44 ± 7.2
|
51.3 (16–78)
|
0.114
|
|
EF > 50%
|
8
|
5
|
44%
|
0.200
|
|
BMI
|
27.6 ± 1.9
|
31.7 ± 3.2
|
29.6 (20–53.7)
|
0.292
|
|
NYHA III
|
1
|
5
|
66%
|
0.049*
|
|
Urgency
|
|
In-hospital
|
4
|
5
|
50%
|
0.637
|
|
Elective
|
5
|
4
|
50%
|
|
Procedure type
|
|
CABG
|
4
|
4
|
8/18
|
0.940
|
|
CABG + valve
|
1
|
1
|
2/18
|
|
Aortic valve
|
3
|
1
|
4/18
|
|
Aortic + mitral valve
|
1
|
1
|
2/18
|
|
LVAD
|
1
|
1
|
2/18
|
|
Clinical frailty
|
|
CFS class 4/5
|
3
|
6
|
50%
|
0.157
|
|
Echocardiogram
|
|
LV diast diameter
|
5.1 ± 0.6
|
5.7 ± 1.1
|
5.5 (4.0–7.3)
|
0.422
|
|
LV syst diameter
|
3.5 ± 0.9
|
4.3 ± 1.9
|
4.0 (2.4–6.9)
|
0.623
|
|
LA diameter
|
4.2 ± 0.8
|
11.1 ± 16.7
|
4.5 (2.8–4.9)
|
0.295
|
|
E/A ratio
|
1.4 ± 1.2
|
0.9 ± 0.1
|
1.2 (0.5–3.7)
|
0.845
|
|
CPB
|
|
Pump time
|
120 ± 38.3
|
107.5 ± 33.1
|
114.1 (65–187)
|
0.689
|
|
LOS (days)
|
9 ± 1.9
|
17 ± 3.1
|
12.8 (5–27)
|
0.026*
|
|
Adverse events
|
|
Delirium
|
2
|
3
|
5/18
|
0.598
|
|
Stroke/TIA
|
0
|
1
|
1/18
|
1.000
|
|
CHF
|
2
|
5
|
7/18
|
0.050*
|
- EF ejection fraction, CABG coronary artery bypass graft, BMI body mass index, CPB cardiopulmonary bypass)
- *Statistically significant
